IP Library Granted Patent US 12,102,795
Granted Patent B2
US 12,102,795 · App. 17/306,022 · Granted Oct 1, 2024

Enhanced confirmations for touchscreen infusion pump

Inventor: Michael J. Rosinko (Anaheim, CA)
Assignee: Tandem Diabetes Care, Inc.
A61M5/172A61M5/142A61M5/1723G06F3/0484G06F21/32G16H20/17G16H20/60G16H40/63G16H50/30A61B5/1171A61B5/1172A61M2005/14208A61M2205/18A61M2205/3592A61M2205/50A61M2205/505A61M2205/52A61M2205/581A61M2205/609
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,102,795
App. No.
17/306,022
Granted
Oct 1, 2024
Kind
B2
Abstract

Enhanced confirmations for programming of touchscreen infusion pumps reduce the likelihood of users confirming pump parameters that have been mistakenly programmed. Following programming of a given pump parameter, an icon or image intuitively related to the pump parameter can be displayed on the touchscreen. To confirm programming of the parameter, the user can be required to trace the icon on the touchscreen. The user will therefore necessarily associate the confirmation step with the parameter being programmed and be far more likely to realize if a mistake has been made because the user was intending to program a different parameter than with simple confirmations involving the press of a confirmation button.

Claims (29)

1. A method of delivering medicament to a user with a portable infusion pump, comprising:

receiving user input programming a bolus delivery of medicament through a touchscreen display;

displaying a first confirmation for the bolus delivery of medicament after receiving the user input programming the bolus delivery of medicament and determining an amount of the bolus delivery of medicament, the first confirmation displaying the amount of the bolus delivery of medicament and a touch-selectable first confirmation input comprising a pictorial icon having a shape related to the bolus delivery of medicament;

receiving a touch-selection of the first confirmation input;

displaying a second confirmation after receiving the first confirmation input, the second confirmation requiring a biometric authentication as a second confirmation input prior to delivering the bolus;

receiving a biometric input as the second confirmation input;

authenticating that the biometric input belongs to an authorized user;

causing the bolus delivery of medicament to be delivered to the authorized user after authenticating the biometric input.

2. The method of claim 1 , wherein receiving the biometric input includes receiving a fingerprint.

3. The method of claim 1 , wherein receiving the biometric input includes performing a retinal scan.

4. The method of claim 1 , wherein authenticating that the biometric input belongs to the authorized user includes facial recognition.

5. The method of claim 1 , further comprising displaying instructional text instructing the user how to confirm the bolus delivery of medicament.

6. The method of claim 1 , wherein receiving the touch-selection of the confirmation input includes receiving only a single touch of the confirmation input.

7. The method of claim 1 , wherein the touchscreen display of the portable infusion pump system is a touchscreen display of the portable infusion pump.

8. The method of claim 1 , wherein the touchscreen display of the portable infusion pump system is a touchscreen display of a remote control device configured to remotely control a portable infusion pump.

9. The method of claim 8 , wherein the remote control device is a smartphone.

10. A method of delivering medicament to a user with a portable infusion pump, comprising;

displaying a first confirmation for a bolus delivery of medicament to be delivered by a portable infusion pump following programming and determination of an amount of the bolus delivery of medicament, the first confirmation displaying an amount of the bolus delivery of medicament and a touch-selectable first confirmation input comprising a pictorial icon related to the bolus delivery of medicament;

displaying a second confirmation after receiving the first confirmation input, the second confirmation requiring a biometric authentication as a second confirmation input to confirm the bolus;

authenticating that a biometric input received in response to the second confirmation belongs to an authorized user; and

causing the bolus delivery of medicament to be delivered to the authorized user after authenticating the biometric input.

11. The method of claim 10 , wherein the received biometric input includes a fingerprint.

12. The method of claim 10 , wherein the received biometric input includes a retinal scan.

13. The method of claim 10 , wherein authenticating the biometric input includes facial recognition.

14. The method of claim 10 , further comprising displaying instructional text instructing the user how to confirm the bolus delivery of medicament.

15. The method of claim 10 , wherein receiving the touch-selection of the confirmation input includes receiving only a single touch of the confirmation icon.

16. The method of claim 10 , wherein the touchscreen display of the portable infusion pump system is a touchscreen display of the portable infusion pump.

17. The method of claim 10 , wherein the touchscreen display of the portable infusion pump system is a touchscreen display of a remote control device configured to remotely control a portable infusion pump.

18. The method of claim 17 , wherein the remote control device is a smartphone.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2024
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: TANDEM DIABETES CARE, INC.
Reel/Frame 066880/0918 →
SECURITY INTEREST Recorded May 25, 2022
From: TANDEM DIABETES CARE, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 060179/0100 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2021
From: ROSINKO, MICHAEL J.
To: TANDEM DIABETES CARE, INC.
Reel/Frame 056114/0157 →